688266 泽璟制药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资0--0000
投资性房地产0--0000
固定资产107,2939.16%98,289109,21499,21281,954
在建工程146,9068.16%135,82786,67327,2459,072
无形资产59,515-14.08%69,27091,030116,291129,514
商誉0--0000
其他非流动资产80,20626.34%63,48589,63997,25780,175
393,9217.37%366,871376,556340,005300,714

流动资产
货币资金2,320,2749.98%2,109,641797,0471,136,6321,149,734
应收账款130,88029.40%101,14088,98562,3710
存货141,12327.31%110,85298,97851,91123,138
其他流动资产113,464-42.90%198,703306,745155,043496,696
2,705,7427.36%2,520,3361,291,7551,405,9561,669,568

流动负债
短期借款914,21014.97%795,165390,793131,80917,670
应付票据4,499--0000
应付帐款124,357-9.71%137,735151,721118,19164,957
其他流动负债126,068-37.68%202,282186,671130,89458,250
1,169,1332.99%1,135,181729,186380,893140,877
流动资产净值1,536,60910.93%1,385,155562,5691,025,0631,528,691
资产总额减流动负债1,930,53010.19%1,752,026939,1261,365,0681,829,405

非流动负债
长期借款0--050,094030,034
应付债券0--0000
其他非流动负债362,164237.87%107,189101,545111,987107,781
362,164237.87%107,189151,639111,987137,815

总权益
    实收股本264,7080.00%264,708240,000240,000240,000
    储备项目1,302,336-4.81%1,368,145519,118956,3231,377,725
股东权益1,567,044-4.03%1,632,853759,1181,196,3231,617,725
非控股权益1,321-88.98%11,98428,36856,75973,864